PD45 Changing The Focus: Evaluation Of Ethical, Legal, Social, And Organizational Issues In Health Technology Assessment Reports For Non-Pharmacological Health Technologies

Introduction Ethical, legal, social, and organizational (ELSO) issues are increasingly recognized in health technology assessment (HTA). However, information retrieval methods for ELSO aspects are scarce, and there are no widely accepted standard methods for developing these analyses. Here, we present the methodology and results of the ELSO analysis included in two HTA reports developed in 2024. Methods Two HTA reports were developed to analyze the value of: (i) genetic testing in congenital hearing loss (cHL); and (ii) a minimally invasive tissue sampling (MITS) technique to determine cause of death. ELSO domains were considered necessary for decision-making. To address the assessment, we conducted scoping reviews to synthesize the evidence, following the PRISMA Extension for Scoping Reviews, and used a prespecified extraction sheet for defining facilitators and barriers. The literature searches included specific search filters for ELSO issues developed by HTA information specialists from the Spanish Network of Agencies for Health Technology Assessment (RedETS). Results The scoping review for ELSO issues in genetic testing for cHL identified 452 references. After eligibility assessment, four reports were included, providing eight ELSO issues: two organizational, two social, and four ethical. Six concerns were facilitators and two were barriers to implementing genetic testing in cHL. The scoping review for ELSO issues in the MITS to determine cause of death identified 903 references. After eligibility assessment, 25 reports were included, bringing forth 43 ELSO concerns: 18 organizational, 15 social, seven ethical, and three legal. Twenty-three issues were facilitators and 20 may be barriers to implementing MITS. Conclusions The analysis of ELSO domains through a scoping review provided crucial information for implementing the two selected technologies. However, challenges remain in ELSO information retrieval: (i) key concepts related to ELSO concerns could be described in a variety of ways; and (ii) ELSO terms are not being used or indexed consistently.

Authors

Publication Details

Journal
International Journal of Technology Assessment in Health Care
Published
2025-12-01
DOI
https://doi.org/10.1017/s0266462325101785
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PD45 Changing The Focus: Evaluation Of Ethical, Legal, Social, And Organizational Issues In Health Technology Assessment Reports For Non-Pharmacological Health Technologies

Joan Segur-Ferrer, Rosa Maria Vivanco‐Hidalgo, Laura Llinàs-Mallol, Rafael Sánchez-Sánchez et al.
International Journal of Technology Assessment in Health Care
BRCA gene mutations in cancer
article

PD45 Changing The Focus: Evaluation Of Ethical, Legal, Social, And Organizational Issues In Health Technology Assessment Reports For Non-Pharmacological Health Technologies

Joan Segur-Ferrer, Rosa Maria Vivanco‐Hidalgo, Laura Llinàs-Mallol, Rafael Sánchez-Sánchez, Edurne Gallastegui-Calvache, Marc Pellicer-Sarasa, Maria Antònia Claveria-Puig, Maria Dolors Estrada Sabadell, Roland Pastells-Peiró
article en

Abstract

Introduction Ethical, legal, social, and organizational (ELSO) issues are increasingly recognized in health technology assessment (HTA). However, information retrieval methods for ELSO aspects are scarce, and there are no widely accepted standard methods for developing these analyses. Here, we present the methodology and results of the ELSO analysis included in two HTA reports developed in 2024. Methods Two HTA reports were developed to analyze the value of: (i) genetic testing in congenital hearing loss (cHL); and (ii) a minimally invasive tissue sampling (MITS) technique to determine cause of death. ELSO domains were considered necessary for decision-making. To address the assessment, we conducted scoping reviews to synthesize the evidence, following the PRISMA Extension for Scoping Reviews, and used a prespecified extraction sheet for defining facilitators and barriers. The literature searches included specific search filters for ELSO issues developed by HTA information specialists from the Spanish Network of Agencies for Health Technology Assessment (RedETS). Results The scoping review for ELSO issues in genetic testing for cHL identified 452 references. After eligibility assessment, four reports were included, providing eight ELSO issues: two organizational, two social, and four ethical. Six concerns were facilitators and two were barriers to implementing genetic testing in cHL. The scoping review for ELSO issues in the MITS to determine cause of death identified 903 references. After eligibility assessment, 25 reports were included, bringing forth 43 ELSO concerns: 18 organizational, 15 social, seven ethical, and three legal. Twenty-three issues were facilitators and 20 may be barriers to implementing MITS. Conclusions The analysis of ELSO domains through a scoping review provided crucial information for implementing the two selected technologies. However, challenges remain in ELSO information retrieval: (i) key concepts related to ELSO concerns could be described in a variety of ways; and (ii) ELSO terms are not being used or indexed consistently.

International Journal of Technology Assessment in Health CareVol. 41(S1)
Peace, Justice and strong institutions
Openalex Percentile: Top 24%
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.